Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • A study of belzutifan and lenvatinib for patients with von Hippel-Lindau disease-associated tumors or other specific solid tumors.

    Recruiting

    3 1 1
    Investigated drugs:
    Belgium Czechia Denmark Finland France Germany +4
  • A Study of Zanidatamab for Patients with Previously Treated HER2-Expressing Solid Tumors

    Recruiting

    2 1 1
    Investigated drugs:
    Spain
  • Study of NGM120 in patients with colorectal cancer and cancer cachexia: Evaluating effects on body weight

    Recruiting

    2 1
    Bulgaria Czechia Hungary Poland Slovakia
  • A study comparing the effectiveness of a simeticone drug combination and a sodium picosulfate drug combination for bowel preparation in patients undergoing colorectal cancer screening.

    Recruiting

    3 1 1 1
    Investigated diseases:
    Spain
  • A study to evaluate the use of FAPI-46 (68Ga) imaging to detect peritoneal cancer spread in patients with colorectal, gastric, ovarian, or pancreatic cancer

    Recruiting

    4 1 1
    The Netherlands Sweden
  • Study of Recovery After Surgery for Colorectal Cancer Using Lidocaine and Ropivacaine in Patients Undergoing Laparoscopic Colorectal Cancer Surgery

    Recruiting

    3 1 1 1
    Investigated diseases:
    France
  • Study of BNT314 and BNT327 with chemotherapy for patients with metastatic colorectal cancer

    Recruiting

    1 1 1
    Investigated drugs:
    Germany Spain
  • Study of melphalan followed by trifluridine-tipiracil and bevacizumab combination versus trifluridine-tipiracil and bevacizumab in liver metastatic colorectal cancer

    Recruiting

    2 1 1 1
    Czechia Germany Italy The Netherlands Spain
  • Study of ONO-4578 and nivolumab with drug combination for first-line treatment in patients with PD-L1 positive advanced colorectal cancer

    Recruiting

    2 1 1 1
    Investigated diseases:
    France Italy Spain
  • A study of futibatinib combined with tislelizumab, fluorouracil, calcium folinate, and oxaliplatin as first-line treatment for patients with colorectal cancer

    Recruiting

    2 1 1 1
    Germany